TOPIRAMATE | A217231 | DR REDDYS LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
SUPERNUS PHARMACEUTICALS, INC. v. DR. REDDY'S LABORATORIES, LTD. et al 10 patentsANDA 217231topiramate | D.N.J. | 2022-07-22 | Terminated 2023-06-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$23.21
per ea
Lowest NADAC/Unit
$3.83
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43598094230TOPIRAMATE ER 200 MG CAPSULE | $23.21 | EA | Generic | — | 2026-06-17 |
| 43598094130TOPIRAMATE ER 100 MG CAPSULE | $10.76 | EA | Generic | — | 2026-06-17 |
| 43598094030TOPIRAMATE ER 50 MG CAPSULE | $6.27 | EA | Generic | — | 2026-06-17 |
| 43598093930TOPIRAMATE ER 25 MG CAPSULE | $3.83 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.